INHBE and anemia: One such inhibitor for activin signals is sotatercept (ACE-011), an activin receptor inhibitor (ActR11A-IgG1Fc) that is in clinical trial Phase II for the treatment of chemotherapy-induced anemia in patients with metastatic non-small cell lung cancer51.